Pharming Group N.V. announces that Pharming’s management will participate in the following investor conference in the month of November:

Pharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the U.S. in the month of September:

Pharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the month of June:

Pharming Group N.V. announces that Pharming’s management will participate in the following investor conference in the month of May:

Pharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the month of April:

Pharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the month of February:

Pharming Group N.V. announces 14 poster presentations by the Company or its collaborators regarding leniolisib and RUCONEST® at the International Primary Immunodeficiencies Congress (IPIC) and the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting in November.

Pharming Group N.V. announces that Pharming’s management will participate in the following investor conference in the month of November:

Pharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the U.S. in the month of September:

Pharming Group N.V. announces that Pharming’s management will attend the following investor conferences in the month of June: